Norio Sakuragawa
Norio Sakuragawa has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Keiko Ohsugi
Department of Inherited Metabolic Disease, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4–1–1, Ogawahigashi, Kodaira, Tokyo 180–8502, Japan
2 shared publicationsM.A. Elwan
Department of Inherited Metabolic Diseases, National Institute of Neuroscience, NCNP, Kodaira, Tokyo, Japan
2 shared publicationsTakashi Ishii
Department of Inherited Metabolic Disease, National Center of Neurology and Psychiatry, Tokyo, Japan
2 shared publicationsF. Ono
The Corporation for Production and Research of Laboratory Primates, Tsukuba, Ibaragi, Japan
1 shared publicationHajime Arai
Department of Neurosurgery, Juntendo School of Medicine, Bunkyo-ku, Tokyo 113, Japan
1 shared publicationHidemi Misawa
Department of Neurology, Tokyo Metropolitan Institute for Neurosciences, 2-6, Musashidai, Fuchu City, Tokyo 183, Japan
1 shared publication
Latest Publications
- 2 June 1999
- Published by Elsevier in Neuroscience Letters
- Vol. 268 (3) , 131-134
Gene expression of oligodendrocyte markers in human amniotic epithelial cells using neural cell-type-specific expression system
- 2 June 1999
- Published by Elsevier in Neuroscience Letters
- Vol. 268 (3) , 131-134
Gene expression of oligodendrocyte markers in human amniotic epithelial cells using neural cell-type-specific expression system
- 21 April 1999
- Published by Wiley in Journal of Neuroscience Research
- Vol. 56 (3) , 316-322
Detection of dopamine D2 receptor mRNA and binding sites in monkey amniotic epithelial cells
- 21 April 1999
- Published by Wiley in Journal of Neuroscience Research
- Vol. 56 (3) , 316-322
Detection of dopamine D2 receptor mRNA and binding sites in monkey amniotic epithelial cells
- 1 April 1999
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 14 (4) , 265-266
Possible Dynamic Neurotransmitter Metabolism Surrounding the Fetus
Human amniotic epithelial cells express makers of glial and neural stem cells. These cells also synthesize and release acetylcholine and catecholamines. This study of amniotic fluid demonstrated that acetylcholine and catecholamines can be readily identified in the fluid. Norepinephrine was the major catecholamine present, although dopamine and DOPAC could also be detected. The physiologic role of these amniotic fluid neurotransmitters in fetal-placental interactions and nervous system development is currently under investigation. (J ChiLd NeuroL 1999;14:265-266).
- 1 April 1999
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 14 (4) , 265-266
Possible Dynamic Neurotransmitter Metabolism Surrounding the Fetus
Human amniotic epithelial cells express makers of glial and neural stem cells. These cells also synthesize and release acetylcholine and catecholamines. This study of amniotic fluid demonstrated that acetylcholine and catecholamines can be readily identified in the fluid. Norepinephrine was the major catecholamine present, although dopamine and DOPAC could also be detected. The physiologic role of these amniotic fluid neurotransmitters in fetal-placental interactions and nervous system development is currently under investigation. (J ChiLd NeuroL 1999;14:265-266).
- 1 July 1998
- Published by Wiley in Journal of Neuroscience Research
- Vol. 53 (1) , 107-113
Synthesis and release of catecholamines by cultured monkey amniotic epithelial cells
In this study, we investigated the presence, possible synthesis, and release of catecholamines (CA) by monkey amniotic epithelial cells (MAEC) using different methods. Immunocytochemical techniques demonstrated the presence of tyrosine hydroxylase (TH), aromatic L‐amino acid decarboxylase (AADC), dopamine‐β‐hydroxylase (DBH), and dopamine (DA) immunoreactivities, suggesting the capability of these cells to synthesize CA. Further evidence from high performance liquid chromatography (HPLC) studies indicated the presence of norepinephrine (NE), DA, and its metabolite 3,4‐dihydroxyphenylacetic acid (DOPAC) in the cell extracts of cultured MAEC. Incubation of MAEC for various time intervals in medium supplemented with L‐tyrosine and tetrahydrobiopterin significantly increased the production of CA, thus confirming active synthesis of CA by MAEC and that increasing the incubation time increases this synthesis. In contrast, pharmacological inhibition of TH by α‐methyl‐p‐tyrosine significantly reduced CA production, further confirming CA synthesis by MAEC. Catecholamines were also detected in the cell incubation media, suggesting the ability of MAEC to spontaneously secrete CA. Moreover, depolarization with high concentration of K+ increased the amount of CA released into the incubation media. Additionally, the detection of DOPAC, a primary metabolite of DA, in MAEC strongly indicates that these cells contain DA metabolizing enzymes. These results demonstrate the presence of CA in MAEC and that these cells can synthesize and release CA. Further extensive studies are needed to fully explore MAEC so that it may serve as a model to study the aspects of catecholaminergic activity in primate cells and may be a possible candidate for allotransplantation therapy of monkey model of Parkinson's disease. J. Neurosci. Res. 53:107–113, 1998.
- 1 July 1998
- Published by Wiley in Journal of Neuroscience Research
- Vol. 53 (1) , 107-113
Synthesis and release of catecholamines by cultured monkey amniotic epithelial cells
In this study, we investigated the presence, possible synthesis, and release of catecholamines (CA) by monkey amniotic epithelial cells (MAEC) using different methods. Immunocytochemical techniques demonstrated the presence of tyrosine hydroxylase (TH), aromatic L‐amino acid decarboxylase (AADC), dopamine‐β‐hydroxylase (DBH), and dopamine (DA) immunoreactivities, suggesting the capability of these cells to synthesize CA. Further evidence from high performance liquid chromatography (HPLC) studies indicated the presence of norepinephrine (NE), DA, and its metabolite 3,4‐dihydroxyphenylacetic acid (DOPAC) in the cell extracts of cultured MAEC. Incubation of MAEC for various time intervals in medium supplemented with L‐tyrosine and tetrahydrobiopterin significantly increased the production of CA, thus confirming active synthesis of CA by MAEC and that increasing the incubation time increases this synthesis. In contrast, pharmacological inhibition of TH by α‐methyl‐p‐tyrosine significantly reduced CA production, further confirming CA synthesis by MAEC. Catecholamines were also detected in the cell incubation media, suggesting the ability of MAEC to spontaneously secrete CA. Moreover, depolarization with high concentration of K+ increased the amount of CA released into the incubation media. Additionally, the detection of DOPAC, a primary metabolite of DA, in MAEC strongly indicates that these cells contain DA metabolizing enzymes. These results demonstrate the presence of CA in MAEC and that these cells can synthesize and release CA. Further extensive studies are needed to fully explore MAEC so that it may serve as a model to study the aspects of catecholaminergic activity in primate cells and may be a possible candidate for allotransplantation therapy of monkey model of Parkinson's disease. J. Neurosci. Res. 53:107–113, 1998.
- 1 August 1997
- Published by Elsevier in Neuroscience Letters
- Vol. 232 (1) , 53-56
Evidence for active acetylcholine metabolism in human amniotic epithelial cells: applicable to intracerebral allografting for neurologic disease
- 1 August 1997
- Published by Elsevier in Neuroscience Letters
- Vol. 232 (1) , 53-56
Evidence for active acetylcholine metabolism in human amniotic epithelial cells: applicable to intracerebral allografting for neurologic disease